KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,872 | -21.3% | 671,311 | -20.3% | 0.29% | -14.4% |
| Q2 2023 | $98,927 | +28.5% | 842,648 | -12.3% | 0.34% | +22.7% |
| Q1 2023 | $76,957 | -24.0% | 961,242 | -24.8% | 0.28% | -23.4% |
| Q4 2022 | $101,245 | -99.9% | 1,278,022 | +5.5% | 0.36% | +17.5% |
| Q3 2022 | $84,473,000 | +15.1% | 1,211,941 | +8.4% | 0.31% | +19.3% |
| Q2 2022 | $73,379,000 | -6.4% | 1,117,566 | -5.2% | 0.26% | +23.9% |
| Q1 2022 | $78,438,000 | -4.5% | 1,178,813 | +0.4% | 0.21% | +11.8% |
| Q4 2021 | $82,112,000 | +47.4% | 1,173,863 | +10.0% | 0.19% | +40.6% |
| Q3 2021 | $55,716,000 | -31.2% | 1,067,158 | -10.4% | 0.13% | -31.8% |
| Q2 2021 | $81,027,000 | -24.1% | 1,191,580 | -14.0% | 0.20% | -28.3% |
| Q1 2021 | $106,750,000 | +1455.4% | 1,385,643 | +1111.5% | 0.27% | +1411.1% |
| Q4 2020 | $6,863,000 | +35.8% | 114,376 | -2.5% | 0.02% | +12.5% |
| Q3 2020 | $5,052,000 | -13.9% | 117,363 | -17.2% | 0.02% | -23.8% |
| Q2 2020 | $5,868,000 | -37.3% | 141,660 | -34.6% | 0.02% | -48.8% |
| Q1 2020 | $9,365,000 | +3.9% | 216,592 | +33.1% | 0.04% | +36.7% |
| Q4 2019 | $9,013,000 | +19.2% | 162,741 | -25.3% | 0.03% | +15.4% |
| Q3 2019 | $7,562,000 | – | 217,750 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |